MOLECULA
MOTS-c (10mg)
Peptides
€20.00
0
Buy with consultation
Concentration:
10 mg
Volume:
5 vials
Buy MOTS-c 5 vials 10mg Peptides online. Premium peptide for fat metabolism, energy production, endurance, performance, and anti-aging.
Description
MOTS-c is a unique mitochondrial-derived peptide (MDP) encoded within the Mitochondrial ORF of the 12S rRNA. It plays a crucial role in cellular energy regulation, metabolic balance, and stress response. By enhancing insulin sensitivity, promoting glucose utilization, and improving mitochondrial function, MOTS-c is an exciting peptide for research into metabolic disorders, exercise performance, and longevity. Why MOTS-c Stands Out Unlike traditional peptides that originate from nuclear DNA, MOTS-c is encoded in mitochondrial DNA, linking it directly to energy production and cellular homeostasis. Research suggests it may help combat age-related metabolic decline, obesity, and insulin resistance: Metabolic Regulation: Enhances glucose uptake and utilization Mitochondrial Function: Supports energy production and stress adaptation Longevity Potential: May contribute to healthy aging and metabolic resilience Key Benefits of MOTS-c ✅ Improves insulin sensitivity & glucose metabolism ✅ Supports weight management and fat oxidation ✅ Enhances cellular energy production ✅ Promotes exercise endurance and recovery ✅ Potential role in healthy aging and longevity research Application & Dosage Guidelines Dosage Range (Research Use): 5 mg to 10 mg per week (varies by study) Administration: Subcutaneous injection (research use only) Frequency: 2–3 times per week (study dependent) Reconstitution: Mix with bacteriostatic or sterile water for injection Storage: Keep refrigerated after mixing (up to 10 days) ⚠️ Safety & Side Effects All dosing information is for research purposes only and not for human consumption unless prescribed by a licensed medical professional. Possible dose-dependent effects may include: Temporary fatigue or mild nausea Hormonal or metabolic fluctuations Rare digestive discomfort Preclinical and clinical studies suggest MOTS-c may be a promising therapeutic candidate for type 2 diabetes, obesity, and age-related metabolic decline.
MOLECULA · 2026